Related Experiment Videos
Chemokines in renal diseases
T Wada1, H Yokoyama, K Matsushima
1First Department of Internal Medicine, Kanazawa University School of Medicine, Japan. twada@medf.m.kanazawa-u.ac.jp
International Immunopharmacology
|May 19, 2001
Summary
Leukocyte and kidney cell interactions drive renal disease. Targeting chemokine and chemokine receptor systems offers potential future therapies for kidney disorders.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Leukocyte-renal cell interactions are key in kidney disease pathogenesis.
- Chemokines and their receptors mediate leukocyte trafficking and activation in diseased kidneys.
Purpose of the Study:
- To elucidate the role of chemokine/chemokine receptor systems in renal disease.
- To explore the potential of anti-chemokine therapy for kidney disorders.
Main Methods:
- Review of recent investigations on chemokine roles in renal pathophysiology.
- Analysis of chemokine receptor expression in renal resident cells.
Main Results:
- Chemokine/chemokine receptor systems are implicated in phase-specific renal disorders.
- Urinary chemokine levels may monitor disease activity.
- Renal resident cell chemokine receptors influence proliferation, fibrogenesis, and chemotaxis.
Conclusions:
- Chemokine systems are critical in renal disease development and progression.
- Targeting chemokine/chemokine receptor interactions presents a promising therapeutic avenue for kidney diseases.